GLPinfo

Sources

All 197 sources cited across GLP Info, in one list. Open a guide to see which source supports which point.

Line illustration of an open book linked to a document, a checklist and a molecule
  1. AEMPS: CIMA medicine database cima.aemps.es
  2. AIFA: medicine database medicinali.aifa.gov.it
  3. Anvisa: GLP-1 prescription-retention rules gov.br
  4. Anvisa: implementation from June 2025 gov.br
  5. ATTAIN-1: original trial publication nejm.org
  6. Austria: BASG medicines register aspregister.basg.gv.at
  7. Belgium: medicines database banquededonneesmedicaments.fagg-afmps.be
  8. Boehringer Ingelheim: October 2026 SYNCHRONIZE-2 update boehringer-ingelheim.com
  9. Boehringer Ingelheim: SYNCHRONIZE-1 results boehringer-ingelheim.com
  10. CDSCO: 2024 approved new drugs including tirzepatide cdsco.gov.in
  11. CDSCO: approved new drugs cdsco.gov.in
  12. COFEPRIS: counterfeit medicine notices gob.mx
  13. College of Sexual and Reproductive Healthcare: GLP-1 agonists and contraception cosrh.org
  14. Danish Medicines Agency laegemiddelstyrelsen.dk
  15. EDE: personal medicine import permit ede.gov.ae
  16. EMA: Bydureon assessment and product information ema.europa.eu
  17. EMA: Byetta assessment and product information ema.europa.eu
  18. EMA: Lyxumia assessment and product information ema.europa.eu
  19. EMA: national registers of authorised medicines ema.europa.eu
  20. EMA: Suliqua product information ema.europa.eu
  21. EMA: Trulicity assessment and product information ema.europa.eu
  22. EMA: Victoza assessment and product information ema.europa.eu
  23. EOF: Greek medicine information services.eof.gr
  24. ESSENCE phase 3 semaglutide trial pubmed.ncbi.nlm.nih.gov
  25. European Commission: checking online medicine retailers health.ec.europa.eu
  26. FCDO: health and medicines in Turkey gov.uk
  27. FDA: Concerns with unapproved GLP-1 drugs fda.gov
  28. FDA: Dosing errors with compounded injectable semaglutide fda.gov
  29. FDA: Foundayo approval fda.gov
  30. FDA: how to check approval fda.gov
  31. FDA: personal importation fda.gov
  32. FDA: Wegovy labelling nctr-crs.fda.gov
  33. FDA: Zepbound and obstructive sleep apnoea fda.gov
  34. FDA: Zepbound prescribing information accessdata.fda.gov
  35. Fimea: Finnish Medicines Agency fimea.fi
  36. Foundayo UK patient information leaflet medicines.org.uk
  37. Foundayo UK Summary of Product Characteristics medicines.org.uk
  38. France: official medicine register via ANSM agence-prd.ansm.sante.fr
  39. Frimley Health NHS: disposal of sharps waste fhft.nhs.uk
  40. FSRH: GLP-1 agonists and contraception fsrh.org
  41. Germany: PharmNet medicine information pharmnet-bund.de
  42. GOV.UK: medicines and medical equipment in hand luggage gov.uk
  43. GOV.UK: request clinical waste collection gov.uk
  44. GOV.UK: travelling with medicine gov.uk
  45. GPhC: guidance for pharmacies providing services at a distance assets.pharmacyregulation.org
  46. GPhC: Online pharmacy safeguards for medicine supply pharmacyregulation.org
  47. GPhC: pharmacy registers pharmacyregulation.org
  48. Guy's and St Thomas' NHS: Food and nutrition with weight loss medicines guysandstthomas.nhs.uk
  49. Health Canada: adolescent Wegovy indication health-products.canada.ca
  50. Health Canada: choosing a safe online pharmacy canada.ca
  51. Health Canada: Drug Product Database health-products.canada.ca
  52. Health Canada: January 2026 conditional MASH indication bulletin canada.ca
  53. Health Canada: marketed Mounjaro KwikPen, DIN 02551969 health-products.canada.ca
  54. Health Canada: marketed Wegovy multidose presentation health-products.canada.ca
  55. Health Canada: Mounjaro paediatric indication, 23 June 2026 health-products.canada.ca
  56. Health Canada: new drug submissions under review, including orforglipron canada.ca
  57. Health Canada: original Mounjaro authorisation dhpp.hpfb-dgpsa.ca
  58. Health Canada: original Wegovy injection authorisation dhpp.hpfb-dgpsa.ca
  59. Health Canada: personal importation guidance GUI-0116 canada.ca
  60. HPRA hpra.ie
  61. HSA: travelling to Singapore with medication hsa.gov.sg
  62. HSA: travelling with medical devices hsa.gov.sg
  63. HSE: needlestick and sharps injuries hse.gov.uk
  64. INFARMED: Portuguese medicines information infarmed.pt
  65. Lilly clinical development pipeline lilly.com
  66. Lilly UK: How many doses are in Mounjaro KwikPen? medical.lilly.com
  67. Lilly: Foundayo US approval and formulation context investor.lilly.com
  68. Lilly: July 2026 retatrutide phase 3 update lilly.gcs-web.com
  69. Lilly: medicine authenticity and retatrutide lilly.com
  70. Lilly: retatrutide clinical study trials.lilly.com
  71. Medsafe: importing medicines medsafe.govt.nz
  72. Medsafe: personal import frequently asked questions medsafe.govt.nz
  73. Mexico City health authority: falsified Ozempic alert agepsa.cdmx.gob.mx
  74. MFDS: traveller controlled-medicine permit information mfds.go.kr
  75. MHLW: medicines for personal use in Japan mhlw.go.jp
  76. MHLW: online Import Confirmation impconf.mhlw.go.jp
  77. MHRA review of GLP-1 medicines and suicidal or self-injurious thoughts gov.uk
  78. MHRA Yellow Card yellowcard.mhra.gov.uk
  79. MHRA Yellow Card reporting forms yellowcard.mhra.gov.uk
  80. MHRA: advice on switching GLP-1 medicines gov.uk
  81. MHRA: authorisation of the 7.2 mg Wegovy dose gov.uk
  82. MHRA: GLP-1 medicines and aspiration gov.uk
  83. MHRA: GLP-1 medicines and rapid insulin reduction gov.uk
  84. MHRA: GLP-1 side effects and potential misuse gov.uk
  85. MHRA: Rybelsus formulation transition gov.uk
  86. MHRA: semaglutide and NAION gov.uk
  87. MHRA: single-dose 7.2 mg Wegovy pen approval gov.uk
  88. MHRA: strengthened pancreatitis warnings gov.uk
  89. MHRA: Supply unlicensed medicinal products (specials) gov.uk
  90. MHRA: UK approval of Foundayo gov.uk
  91. MHRA: UK approval of Wegovy tablets gov.uk
  92. Ministry of Food and Drug Safety mfds.go.kr
  93. MOHAP: transfer of services to EDE mohap.gov.ae
  94. Mounjaro UK patient information leaflet medicines.org.uk
  95. Mounjaro: UK prescribing information medicines.org.uk
  96. Netherlands: Medicines Information Bank geneesmiddeleninformatiebank.nl
  97. NHS Cheshire and Merseyside: tirzepatide access cohorts cheshireandmerseyside.nhs.uk
  98. NHS England: weight management injections england.nhs.uk
  99. NHS Fit for Travel: travelling with medicines fitfortravel.scot.nhs.uk
  100. NHS Specialist Pharmacy Service: GLP-1 considerations and interactions sps.nhs.uk
  101. NHS Specialist Pharmacy Service: Understanding unlicensed medicines sps.nhs.uk
  102. NHS: acute kidney injury nhs.uk
  103. NHS: acute pancreatitis nhs.uk
  104. NHS: Alcohol units nhs.uk
  105. NHS: Anorexia nervosa nhs.uk
  106. NHS: constipation nhs.uk
  107. NHS: dehydration nhs.uk
  108. NHS: diabetic retinopathy nhs.uk
  109. NHS: feeling sick (nausea) nhs.uk
  110. NHS: gallstones nhs.uk
  111. NHS: Hair loss nhs.uk
  112. NHS: heartburn and acid reflux nhs.uk
  113. NHS: How to get more fibre into your diet nhs.uk
  114. NHS: Insomnia nhs.uk
  115. NHS: low blood sugar nhs.uk
  116. NHS: Malnutrition nhs.uk
  117. NHS: Overweight and obesity in adults nhs.uk
  118. NHS: Physical activity guidelines for adults aged 19 to 64 nhs.uk
  119. NHS: Physical activity guidelines for older adults nhs.uk
  120. NHS: semaglutide nhs.uk
  121. NHS: The Eatwell Guide nhs.uk
  122. NHS: Tiredness and fatigue nhs.uk
  123. NHS: tirzepatide nhs.uk
  124. NHS: vomiting and urgent warning signs nhs.uk
  125. NHS: Walking for health nhs.uk
  126. NICE NG197: Shared decision making nice.org.uk
  127. NICE NG246: Overweight and obesity management nice.org.uk
  128. NICE NG28: type 2 diabetes in adults nice.org.uk
  129. NICE TA1026: recommendations nice.org.uk
  130. NICE TA1152 cardiovascular recommendation nice.org.uk
  131. NICE TA1152: semaglutide for cardiovascular risk reduction nice.org.uk
  132. NICE TA664: liraglutide for weight management nice.org.uk
  133. NICE TA875: semaglutide for weight management nice.org.uk
  134. NICE: A guide for prescribing medicines to manage overweight and obesity nice.org.uk
  135. NICE: prescribing, reviewing and stopping tirzepatide nice.org.uk
  136. NMPA official portal nmpa.gov.cn
  137. NMPA: drugs english.nmpa.gov.cn
  138. Norway: medicine search legemiddelsok.no
  139. Novo Nordisk: CagriSema mechanistic data, September 2026 novonordisk.com
  140. Novo Nordisk: current development pipeline novonordisk.com
  141. Novo Nordisk: obesity development presentation, September 2026 novonordisk.com
  142. Novo Nordisk: September 2026 CagriSema trial update novonordisk.com
  143. Novo Nordisk: zenagamtide phase 2 poster, ADA 2026 sciencehub.novonordisk.com
  144. OASIS 4: original trial publication nejm.org
  145. Ozempic UK patient information and pen instructions medicines.org.uk
  146. Ozempic: patient information leaflet medicines.org.uk
  147. Ozempic: UK prescribing information medicines.org.uk
  148. Pharmaceutical Society of Northern Ireland psni.org.uk
  149. PMDA: approved medicine information pmda.go.jp
  150. PMDA: Japanese approvals in FY2022, including Mounjaro and Wegovy pmda.go.jp
  151. PMDA: Japanese Mounjaro prescribing information pmda.go.jp
  152. PMDA: Japanese Zepbound clinical information pmda.go.jp
  153. PMDA: Zepbound Japanese review report pmda.go.jp
  154. Poland: medical registers rejestrymedyczne.ezdrowie.gov.pl
  155. Rybelsus: UK prescribing information medicines.org.uk
  156. SAHPRA: 2026 enforcement action on unregistered GLP-1 products sahpra.org.za
  157. SAHPRA: semaglutide questions and answers sahpra.org.za
  158. Saudi Food and Drug Authority sfda.gov.sa
  159. Saxenda: UK prescribing information medicines.org.uk
  160. SELECT cardiovascular outcomes trial pubmed.ncbi.nlm.nih.gov
  161. SELECT: original trial publication nejm.org
  162. SFDA: controlled medicines for travellers sfda.gov.sa
  163. STEP 1 extension after withdrawal pubmed.ncbi.nlm.nih.gov
  164. STEP 1 randomised trial pubmed.ncbi.nlm.nih.gov
  165. STEP 1: original trial publication nejm.org
  166. STEP 4 continued treatment and withdrawal trial pubmed.ncbi.nlm.nih.gov
  167. STEP 5: two-year semaglutide trial pubmed.ncbi.nlm.nih.gov
  168. STEP 8: original randomised comparison jamanetwork.com
  169. SURMOUNT-1: original trial publication nejm.org
  170. SURMOUNT-1: tirzepatide once weekly for obesity pubmed.ncbi.nlm.nih.gov
  171. SURMOUNT-4: Continued tirzepatide and weight maintenance jamanetwork.com
  172. SURMOUNT-4: continued tirzepatide for maintenance of weight reduction pmc.ncbi.nlm.nih.gov
  173. SURMOUNT-5: original trial publication nejm.org
  174. Swedish Medical Products Agency lakemedelsverket.se
  175. Swissmedic: entering Switzerland with medicines swissmedic.ch
  176. Swissmedic: personal imports and the internet swissmedic.ch
  177. SYNCHRONIZE-1: original publication nejm.org
  178. TGA: entering Australia with medicines tga.gov.au
  179. TGA: Mounjaro indications and updated contraception advice tga.gov.au
  180. TGA: Mounjaro weight-management registration tga.gov.au
  181. TGA: orforglipron application under evaluation tga.gov.au
  182. TGA: original Wegovy registration tga.gov.au
  183. TGA: Personal Importation Scheme tga.gov.au
  184. TGA: Wegovy adolescent indication tga.gov.au
  185. TGA: Wegovy assessment report and separate Rybelsus history tga.gov.au
  186. TGA: Wegovy cardiovascular indication tga.gov.au
  187. TGA: Wegovy MASH indication tga.gov.au
  188. UK multidisciplinary perioperative consensus pmc.ncbi.nlm.nih.gov
  189. UK Parliament: liraglutide supply and Victoza discontinuation questions-statements.parliament.uk
  190. Wegovy 7.2 mg single-dose pen leaflet medicines.org.uk
  191. Wegovy FlexTouch patient leaflet medicines.org.uk
  192. Wegovy FlexTouch UK patient leaflet and pen instructions medicines.org.uk
  193. Wegovy FlexTouch UK prescribing information medicines.org.uk
  194. Wegovy injection: UK prescribing information medicines.org.uk
  195. Wegovy pill UK patient information leaflet medicines.org.uk
  196. Wegovy tablets: UK prescribing information medicines.org.uk
  197. Your Europe: prescriptions in another EU country europa.eu

Try Mounjaro nausea, Wegovy pill, missed dose or Spain.

Browse all 228 guides A to Z